Stegeman C - Search Results

1

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U; RAVE-ITN Research Group. Stone JH, et al. Among authors: stegeman c. N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.

2

Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies.

Kallenberg CG, Tervaert JW, Stegeman CA. Kallenberg CG, et al. Among authors: stegeman ca. APMIS Suppl. 1990;19:37-9. doi: 10.1111/j.1600-0463.1990.tb05725.x. APMIS Suppl. 1990. PMID: 2285535 Review. No abstract available.

3

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA.

Mulder AH, Stegeman CA, Kallenberg CG. Mulder AH, et al. Among authors: stegeman ca. Clin Exp Immunol. 1995 Aug;101(2):227-32. doi: 10.1111/j.1365-2249.1995.tb08343.x. Clin Exp Immunol. 1995. PMID: 7648707 Free PMC article.

4

ANCA--pathophysiology revisited.

Kallenberg CG, Brouwer E, Mulder AH, Stegeman CA, Weening JJ, Tervaert JW. Kallenberg CG, et al. Among authors: stegeman ca. Clin Exp Immunol. 1995 Apr;100(1):1-3. doi: 10.1111/j.1365-2249.1995.tb03594.x. Clin Exp Immunol. 1995. PMID: 7697907 Free PMC article. Review. No abstract available.

5

Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis.

Stegeman CA, Tervaert JW, Kallenberg CG. Stegeman CA, et al. Ann Med Interne (Paris). 1994;145(8):523-32. Ann Med Interne (Paris). 1994. PMID: 7710178 Review. No abstract available.

6

Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.

Tervaert JW, Stegeman CA, Brouwer E, Mulder AH, Limburg PC, Kallenberg CG. Tervaert JW, et al. Among authors: stegeman ca. Neth J Med. 1994 Dec;45(6):262-72. Neth J Med. 1994. PMID: 7838242 Review.

7

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG. Brouwer E, et al. Among authors: stegeman ca. Clin Exp Immunol. 1994 Dec;98(3):448-53. doi: 10.1111/j.1365-2249.1994.tb05511.x. Clin Exp Immunol. 1994. PMID: 7994909 Free PMC article.

8

Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et al.

Tervaert JW, Stegeman CA, Huitema MG, Kallenberg CG. Tervaert JW, et al. Among authors: stegeman ca. Arthritis Rheum. 1994 Apr;37(4):596-7. doi: 10.1002/art.1780370424. Arthritis Rheum. 1994. PMID: 8147939 No abstract available.

9

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.

Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Stegeman CA, et al. Ann Intern Med. 1994 Jan 1;120(1):12-7. doi: 10.7326/0003-4819-120-1-199401010-00003. Ann Intern Med. 1994. PMID: 8250451

10

Serum markers of T-cell activation in relapses of Wegener's granulomatosis.

Stegeman CA, Tervaert JW, Huitema MG, Kallenberg CG. Stegeman CA, et al. Adv Exp Med Biol. 1993;336:389-92. doi: 10.1007/978-1-4757-9182-2_67. Adv Exp Med Biol. 1993. PMID: 8296642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page